Literature DB >> 18004230

Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis.

Jessica A Clark1, Andrew T Clark, Richard S Hotchkiss, Timothy G Buchman, Craig M Coopersmith.   

Abstract

Epidermal growth factor (EGF) is a cytoprotective peptide that has healing effects on the intestinal mucosa. We sought to determine whether systemic administration of EGF after the onset of sepsis improved intestinal integrity and decreased mortality. FVB/N mice were subjected to either sham laparotomy or 2 x 23 cecal ligation and puncture (CLP). Septic mice were further randomized to receive injection of either 150 microg kg(-1) d(-1) (i.p.) EGF or 0.9% saline (i.p.). Circulating EGF levels were decreased after CLP compared with sham animals but were unaffected by giving exogenous EGF treatment. In contrast, intestinal EGF levels increased after CLP and were further augmented by exogenous EGF treatment. Intestinal EGF receptor was increased after CLP, whether assayed by immunohistochemistry, real-time polymerase chain reaction, or Western blot, and exogenous EGF treatment decreased intestinal EGF receptor. Villus length decreased 2-fold between sham and septic animals, and EGF treatment resulted in near total restitution of villus length. Sepsis decreased intestinal proliferation and increased intestinal apoptosis. This was accompanied by increased expression of the proapoptotic proteins Bid and Fas-associated death domain, as well as the cyclin-dependent kinase inhibitor p21 cip1/waf Epidermal growth factor treatment after the onset of sepsis restored both proliferation and apoptosis to levels seen in sham animals and normalized expression of Bid, Fas-associated death domain, and p21 cip1/waf . To determine whether improvements in gut homeostasis were associated with a decrease in sepsis-induced mortality, septic mice with or without EGF treatment after CLP were followed 7 days for survival. Mortality decreased from 60% to 30% in mice treated with EGF after the onset of sepsis (P < 0.05). Thus, EGF may be a potential therapeutic agent for the treatment of sepsis in part due to its ability to protect intestinal integrity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18004230      PMCID: PMC2551558          DOI: 10.1097/shk.0b013e31815D0820

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  37 in total

1.  Why is epidermal growth factor present in the gut lumen?

Authors:  R J Playford; N A Wright
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types.

Authors:  H Cheng; C P Leblond
Journal:  Am J Anat       Date:  1974-12

Review 4.  The epidermal growth factor (EGF).

Authors:  S Cohen
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

5.  Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro.

Authors:  Douglas A Potoka; Jeffrey S Upperman; Xiao-Ru Zhang; Joshua R Kaplan; Seth J Corey; Anatoly Grishin; Ruben Zamora; Henri R Ford
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-07-03       Impact factor: 4.052

6.  Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model.

Authors:  C C Baker; I H Chaudry; H O Gaines; A E Baue
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

7.  Effect of epidermal growth factor, transforming growth factor alpha and nerve growth factor on gastric mucosal integrity and microcirculation in the rat.

Authors:  B L Tepperman; B D Soper
Journal:  Regul Pept       Date:  1994-02-03

8.  Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route, and timing of administration.

Authors:  C E Shin; M A Helmrath; R A Falcone; J W Fox; K R Duane; C R Erwin; B W Warner
Journal:  J Surg Res       Date:  1998-06       Impact factor: 2.192

9.  Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor.

Authors:  P J Miettinen; J E Berger; J Meneses; Y Phung; R A Pedersen; Z Werb; R Derynck
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

10.  Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis.

Authors:  P A Hall; P J Coates; B Ansari; D Hopwood
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

View more
  35 in total

1.  Cecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines.

Authors:  Enjae Jung; Erin E Perrone; Zhe Liang; Elise R Breed; Jessica A Dominguez; Andrew T Clark; Amy C Fox; W Michael Dunne; Eileen M Burd; Alton B Farris; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Shock       Date:  2012-01       Impact factor: 3.454

Review 2.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis.

Authors:  Erin E Perrone; Enjae Jung; Elise Breed; Jessica A Dominguez; Zhe Liang; Andrew T Clark; W Michael Dunne; Eileen M Burd; Craig M Coopersmith
Journal:  Shock       Date:  2012-07       Impact factor: 3.454

4.  Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.

Authors:  R E Vandenbroucke; I Vanlaere; F Van Hauwermeiren; E Van Wonterghem; C Wilson; C Libert
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

5.  Dietary bile acid supplementation improves intestinal integrity and survival in a murine model.

Authors:  Erin E Perrone; Chen Chen; Shannon W Longshore; Oneybuchi Okezie; Brad W Warner; Chen-Chih Sun; Samuel M Alaish; Eric D Strauch
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

6.  Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality.

Authors:  Amy C Fox; Elise R Breed; Zhe Liang; Andrew T Clark; Brendan R Zee-Cheng; Katherine C Chang; Jessica A Dominguez; Enjae Jung; W Michael Dunne; Eileen M Burd; Alton B Farris; David C Linehan; Craig M Coopersmith
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

Review 7.  Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.

Authors:  Anna E Kersh; Spencer Ng; Yun Min Chang; Maiko Sasaki; Susan N Thomas; Haydn T Kissick; Gregory B Lesinski; Ragini R Kudchadkar; Edmund K Waller; Brian P Pollack
Journal:  J Clin Pharmacol       Date:  2017-11-14       Impact factor: 3.126

8.  Regulators of Intestinal Epithelial Migration in Sepsis.

Authors:  Mei Meng; Nathan J Klingensmith; Zhe Liang; John D Lyons; Katherine T Fay; Ching-Wen Chen; Mandy L Ford; Craig M Coopersmith
Journal:  Shock       Date:  2019-01       Impact factor: 3.454

9.  Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation.

Authors:  Héctor Diez; Ma José Benitez; Silvia Fernandez; Ignacio Torres-Aleman; Juan José Garrido; Francisco Wandosell
Journal:  Biochim Biophys Acta       Date:  2016-07-12

10.  Epidermal Growth Factor Improves Intestinal Integrity and Survival in Murine Sepsis Following Chronic Alcohol Ingestion.

Authors:  Nathan J Klingensmith; Benyam P Yoseph; Zhe Liang; John D Lyons; Eileen M Burd; Lindsay M Margoles; Michael Koval; Mandy L Ford; Craig M Coopersmith
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.